ReviewMolecular therapy oncolytics2022
Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges.
Alessandro Poggi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
43 papers cite it
this papertrialcites it